Rituximab

Common brands: Rituxan, Prednisone, Prednisone Delayed Release, Prednisone Tablets, Usp, 10 Mg, Prednisone Tablets, Usp, 20 Mg

Top reporter: Genentech, Inc.

CD20-directed Cytolytic Antibody [EPC]Corticosteroid [EPC]Alkylating Drug [EPC]Folate Analog Metabolic Inhibitor [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]
205,592
Total Reports
109,381
Serious Reports
36,036
Death Reports
30
Reported Reactions
Death Report Ratio: High (17.53%)

Patient Demographics

Male
66,768
Female
94,464

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Rituximab.

# Reaction Reports % of Total
1 OFF LABEL USE 39,617
10.2%
2 DRUG INEFFECTIVE 33,592
8.6%
3 RHEUMATOID ARTHRITIS 19,804
5.1%
4 PAIN 17,435
4.5%
5 FATIGUE 16,912
4.4%
6 RASH 13,186
3.4%
7 ARTHRALGIA 13,074
3.4%
8 PNEUMONIA 12,492
3.2%
9 INFUSION RELATED REACTION 12,419
3.2%
10 DRUG INTOLERANCE 12,256
3.2%
11 JOINT SWELLING 11,663
3.0%
12 PYREXIA 11,463
2.9%
13 NAUSEA 11,384
2.9%
14 INFECTION 10,817
2.8%
15 ALOPECIA 10,666
2.7%
16 CONTRAINDICATED PRODUCT ADMINISTERED 10,225
2.6%
17 ABDOMINAL DISCOMFORT 10,204
2.6%
18 DYSPNOEA 10,019
2.6%
19 HEADACHE 9,712
2.5%
20 TREATMENT FAILURE 9,551
2.5%
21 DRUG HYPERSENSITIVITY 9,514
2.4%
22 CONDITION AGGRAVATED 9,504
2.4%
23 SYSTEMIC LUPUS ERYTHEMATOSUS 9,479
2.4%
24 DIARRHOEA 9,459
2.4%
25 INTENTIONAL PRODUCT USE ISSUE 9,283
2.4%
26 PEMPHIGUS 9,138
2.4%
27 ARTHROPATHY 9,083
2.3%
28 HYPERSENSITIVITY 9,078
2.3%
29 SWELLING 9,022
2.3%
30 SYNOVITIS 8,572
2.2%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.